Literature DB >> 18930124

Human phenotypes associated with GATA-1 mutations.

Wendy A Ciovacco1, Wendy H Raskind, Melissa A Kacena.   

Abstract

GATA-1 is one of the six members of the GATA gene family, a group of related transcription factors discovered in the 1980s. In the past few decades, the crucial role of GATA-1 in normal human hematopoiesis has been delineated. As would be expected, mutations in GATA-1 have subsequently been found to have important clinical significance, and are directly linked to deregulated formation of certain blood cell lineages. This paper reviews the functional consequences of GATA-1 mutations by linking specific errors in the gene, or its downstream protein products, to documented human diseases. These five human diseases are: X-linked thrombocytopenia (XLT), X-linked thrombocytopenia with thalassemia (XLTT), congenital erythropoietic porphyria (CEP), transient myeloproliferative disorder (TMD) and acute megarakaryoblastic leukemia (AMKL) associated with Trisomy 21, and, lastly, a particular subtype of anemia associated with the production of GATA-1s, a shortened, mutant isoform of the wild-type GATA-1. The different phenotypic expressions associated with GATA-1 mutations illustrate the integral function of the transcription factor in overall body homeostasis. Furthermore, these direct genotype-phenotype correlations reinforce the importance of unraveling the human genome, as such connections may lead to important therapeutic or preventive therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930124      PMCID: PMC2601579          DOI: 10.1016/j.gene.2008.09.018

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  48 in total

Review 1.  Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.

Authors:  Kinuko Ohneda; Masayuki Yamamoto
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

Review 2.  Core-binding factors in haematopoiesis and leukaemia.

Authors:  Nancy A Speck; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Authors:  Joshua Wechsler; Marianne Greene; Michael A McDevitt; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

4.  RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.

Authors:  Kamaleldin E Elagib; Frederick K Racke; Michael Mogass; Rina Khetawat; Lorrie L Delehanty; Adam N Goldfarb
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

5.  X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction.

Authors:  Channing Yu; Kathy K Niakan; Mark Matsushita; George Stamatoyannopoulos; Stuart H Orkin; Wendy H Raskind
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

6.  Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.

Authors:  Lucas Waltzer; Géraldine Ferjoux; Laetitia Bataillé; Marc Haenlin
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

7.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

Authors:  Motoshi Ichikawa; Takashi Asai; Toshiki Saito; Sachiko Seo; Ieharu Yamazaki; Tetsuya Yamagata; Kinuko Mitani; Shigeru Chiba; Seishi Ogawa; Mineo Kurokawa; Hisamaru Hirai
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

8.  Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.

Authors:  Carlo L Balduini; Alessandro Pecci; Giuseppe Loffredo; Paola Izzo; Patrizia Noris; Michela Grosso; Gaetano Bergamaschi; Vittorio Rosti; Umberto Magrini; Iride F Ceresa; Valeria Conti; Vincenzo Poggi; Anna Savoia
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

9.  Essential and instructive roles of GATA factors in eosinophil development.

Authors:  Ryutaro Hirasawa; Ritsuko Shimizu; Satoru Takahashi; Mitsujiro Osawa; Shu Takayanagi; Yuko Kato; Masafumi Onodera; Naoko Minegishi; Masayuki Yamamoto; Katashi Fukao; Hideki Taniguchi; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

10.  GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant.

Authors:  Anna Rita Migliaccio; Rosa Alba Rana; Massimo Sanchez; Rodolfo Lorenzini; Lucia Centurione; Lucia Bianchi; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  35 in total

1.  Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.

Authors:  Ulrich Dührsen; Christian P Kratz; Christian Flotho; Thomas Lauenstein; Martin Bommer; Erika König; Günter Brittinger; Hermann Heimpel
Journal:  Ann Hematol       Date:  2010-10-05       Impact factor: 3.673

Review 2.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

3.  Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression.

Authors:  Timothy M Chlon; Louis C Doré; John D Crispino
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

4.  Analysis of disease-causing GATA1 mutations in murine gene complementation systems.

Authors:  Amy E Campbell; Lorna Wilkinson-White; Joel P Mackay; Jacqueline M Matthews; Gerd A Blobel
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

5.  Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.

Authors:  Eva Zetterberg; Maria Verrucci; Fabrizio Martelli; Maria Zingariello; Laura Sancillo; Emanuela D'Amore; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Platelets       Date:  2013-10-31       Impact factor: 3.862

6.  GATA1 erythroid-specific regulation of SEC23B expression and its implication in the pathogenesis of congenital dyserythropoietic anemia type II.

Authors:  Roberta Russo; Immacolata Andolfo; Antonella Gambale; Gianluca De Rosa; Francesco Manna; Alessandra Arillo; Farooq Wandroo; Maria Grazia Bisconte; Achille Iolascon
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

Review 7.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

8.  Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes.

Authors:  Annarita Miccio; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2010-05-03       Impact factor: 4.272

9.  An Efficient Method to Identify Conditionally Activated Transcription Factors and their Corresponding Signal Transduction Pathway Segments.

Authors:  Haiyan Hu
Journal:  Bioinform Biol Insights       Date:  2009-11-17

10.  GATA3 is a master regulator of the transcriptional response to low-dose ionizing radiation in human keratinocytes.

Authors:  Florian Bonin; Manuella Molina; Claude Malet; Chantal Ginestet; Odile Berthier-Vergnes; Michèle T Martin; Jérôme Lamartine
Journal:  BMC Genomics       Date:  2009-09-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.